H3B-6545 is an Orally Active and Selective ER Covalent Antagonist (SERCA)

Breast cancer is the second leading cause of cancer mortality among women worldwide. Estrogen receptor alpha (ERα) is a key hormone-regulated transcription factor for normal and malignant breast cells. Moreover,…